Articles by Patricia Van Arnum - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Patricia Van Arnum

Applying Catalysis to Optimize API Synthesis

Fine-chemical companies, contract manufacturers, and researchers advance chemocatalysis and biocatalysis.
Nov 2, 2013

Fine-chemical companies, contract manufacturers, and researchers advance chemocatalysis and biocatalysis.

AstraZeneca Received Mixed Decision on US Patent Litigation

Nov 1, 2013

A US court of appeals rules on patent litigation for AstraZeneca's asthma drug Pulmicort Respules (budesonide).

A Strong Outlook for Global Pharma Outsourcing

Oct 23, 2013

Overall growth in the market for pharmaceutical contract research and manufacturing is strong although growth in established markets erodes at the expense of emerging markets.

Quality by Design in APIs

The adoption of quality by design in small-molecule drug development and manufacturing continues to evolve as the industry seeks ways to augment process understanding for APIs
Oct 23, 2013

The adoption of quality by design in small-molecule drug development and manufacturing continues to evolve as the industry seeks ways to augment process understanding for APIs.

Evaluating Strategies for Oral Absorption Enhancement

Formulation scientists tackle the challenges of improving drug absorption across the gastrointestinal membrane.
Oct 23, 2013

Formulation scientists tackle the challenges of improving drug absorption across the gastrointestinal membrane.

Cambridge Major Laboratories Discusses Strategy on its Merger with AAIPharma Services

Oct 22, 2013

Brian Scanlan, CEO and president of Cambridge Major Laboratories, discusses the rationale behind the company's merger with AAIPharma Services.

Tracking Biologics Manufacturing Investment by Big Pharma

Oct 17, 2013

Roche's plans for a major biologics manufacturing expansion is the latest investment by Big Pharma

Pharma Companies and CMOs Invest in ADC Technology

Oct 17, 2013

AstraZeneca and SAFC are the latest companies to expand positions in antibody drug conjugates (ADCs).

Tracking Biotech Financing

Global biotechnology financing through the first nine months of 2013 shows that initial public offerings are on the rise while venture-capital funding stays relatively flat.
Oct 9, 2013

Global biotechnology financing through the first nine months of 2013 shows that initial public offerings are on the rise while venture-capital funding stays relatively flat.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
22%
Attracting a skilled workforce
30%
Obtaining/maintaining adequate financing
11%
Regulatory compliance
37%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
FindPharma Custom Search
Click here